simvastatin has been researched along with Pituitary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alhambra-Expósito, MR; Barrera-Martín, A; Blanco-Acevedo, C; Castaño, JP; Dios, E; Fanciulli, A; Fuentes-Fayos, AC; Gahete, MD; Gálvez-Moreno, MA; Granata, R; Herrera-Martínez, AD; Kineman, RD; L-López, F; Luque, RM; Moreno-Moreno, P; Solivera, J; Soto-Moreno, A; Vázquez-Borrego, MC; Venegas-Moreno, E | 1 |
1 other study(ies) available for simvastatin and Pituitary Neoplasms
Article | Year |
---|---|
Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary Tumors.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Metformin; Mice; Middle Aged; Neuroendocrine Tumors; Papio anubis; Pituitary Gland; Pituitary Neoplasms; Rats; Simvastatin; Somatostatin; Young Adult | 2020 |